Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Oncologic
100%
PET-MRI
100%
Diagnostic Study
28%
Computed Tomography Findings
21%
Standard of Care
14%
Malignancy
14%
Image Interpretation
14%
FDG-avid
14%
Treatment Monitoring
7%
Inflammation
7%
Clinical Examination
7%
FDG Uptake
7%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
7%
Treatment Effect
7%
Diffusion-weighted Imaging
7%
Clinical Utility
7%
Tumor Invasion
7%
Medicine Services
7%
Fluorodeoxyglucose
7%
Local Recurrence
7%
Nuclear Medicine
7%
Lymphadenopathy
7%
Accurate Localization
7%
Oncology Patients
7%
Incidental
7%
MRI Study
7%
Subsequent Therapy
7%
Solid Organ
7%
Clinical Value
7%
Cellular Density
7%
Total-body PET/CT
7%
Staged Treatment
7%
Initial Staging
7%
Tumor Staging
7%
Soft-tissue Contrast
7%
Follow-up Imaging
7%
Lesion Characterization
7%
FDG Positron Emission Tomography/computed Tomography
7%
Whole-body Positron Emission Tomography/computed Tomography
7%
High Background
7%
Non-FDG
7%
Action Localization
7%
Organ Lesion
7%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography - Magnetic Resonance Imaging
100%
Diagnosis
35%
Cancer
14%
Magnetic Resonance Imaging
14%
Computed Tomography Studies
14%
Whole Body PET
14%
Polyethylene Terephthalate
14%
Treatment Response
7%
Infection
7%
Clinical Examination
7%
Lymphadenopathy
7%
Fluorodeoxyglucose F 18
7%
Recurrent Disease
7%
Oncology
7%
Treatment Effect
7%
Tumor Invasion
7%
Cancer Staging
7%
Diffusion MRI
7%
Cell Density
7%
Nuclear Medicine
7%